EMT is a critical early event in tumor progression and is characterized by the down-regulation of epithelial markers (e.g., E-cadherin, β-catenin) and the up-regulation of mesenchymal markers (e.g., Vimentin, N-cadherin) [10]. Here, CDH1 is linked to neoplasm.